Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.95Price to Sales
VS
Market
Sector
Industry
History
$ 2.66Close
$ 2.45 - $ 65.4 52-Week Range
Ticker Information
Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQBIOAFFINITY TECHNOLOGIES INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BIAF - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 7.27M | 0.95 | $ 7.68M |
| 3/31/2025 | $ 5.6M | 0.64 | $ 8.81M |
| 12/31/2024 | $ 4.75M | 0.51 | $ 9.36M |
| 9/30/2024 | $ 20.73M | 2.21 | $ 9.37M |
| 6/30/2024 | $ 23.94M | 3.27 | $ 7.32M |
| 3/31/2024 | $ 21.92M | 4.44 | $ 4.94M |
| 12/31/2023 | $ 24.07M | 9.5 | $ 2.53M |
| 9/30/2023 | $ 13.69M | 42.59 | $ 321.49K |
| 6/30/2023 | $ 16.25M | 672.65 | $ 24.16K |
| 3/31/2023 | $ 15.25M | 2.67K | $ 5.72K |
Key Performance Insights, Last 5 Years
- BIOAFFINITY TECHNOLOGIES INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, BIOAFFINITY TECHNOLOGIES INC's average P/S has been 612.04.
- The median P/S for BIOAFFINITY TECHNOLOGIES INC during this period was 4.44
- BIOAFFINITY TECHNOLOGIES INC reached its highest P/S over the past 5 years at 3.33K.
- The lowest P/S recorded by BIOAFFINITY TECHNOLOGIES INC in the same timeframe 0.51
BIOAFFINITY TECHNOLOGIES INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] BIAF - Price to Sales, Last 5 years
0.51
Minimum
Dec 31, 2024
3.33K
Maximum
Dec 31, 2022
612.04
Average
4.44
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |